FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000413955> ?p ?o ?g. }

• W3000413955 endingPage "1430" @default.
• W3000413955 startingPage "1422" @default.
• W3000413955 abstract "Pharmacists' role in addressing the opioid crisis continues to expand, but lack of training specifically related to standardized prescription drug monitoring program (PDMP) use and communication strategies for provider and patient interactions remains a significant issue. We developed the Resources Encouraging Safe Prescription Opioid and Naloxone Dispensing (RESPOND) Toolkit to enhance community pharmacists’ understanding of their role in addressing opioid safety; improve integration of PDMP into daily workflow; and enhance communication between pharmacists, prescribers, and patients. To describe the development of RESPOND Toolkit and summarize findings from initial pilot testing. RESPOND development was informed by focus groups with patients, prescribers, and pharmacists and an external advisory committee. Materials developed include a patient screening & communication algorithm, a provider communication checklist and an online continuing education course with three distinct modules. The RESPOND Toolkit was pilot tested in six community pharmacies in Oregon across two 6-month intervention phases. Pilot data collection included a pre-post intervention survey, pre-post knowledge assessment quizzes within the online course, and post-intervention semi-structured interviews. Interview feedback informed revisions after each phase to shape the final content, flow, and delivery of RESPOND. Sixteen of 21 pharmacists completed the online training, revealing a large, significant effect on knowledge gain across the three training modules (pre-score 57, post-score 84; p < 0.001; Cohen's d = 1.85). Of these participants, 10 also completed the baseline and post intervention survey and showed non-significant moderate improvements in knowledge, perceived behavioral control, and self-efficacy to address opioid safety issues. The RESPOND Toolkit has promise as an effective and scalable approach to providing community pharmacist-tailored training, especially in the areas of effective communication and workflow integration, to promote behavioral shifts supporting opioid safety for patients. Further development and testing in a larger sample is warranted." @default.
• W3000413955 created "2020-01-23" @default.
• W3000413955 creator A5000479274 @default.
• W3000413955 creator A5000998928 @default.
• W3000413955 creator A5032055005 @default.
• W3000413955 creator A5065055672 @default.
• W3000413955 creator A5068219229 @default.
• W3000413955 creator A5084986801 @default.
• W3000413955 creator A5086002607 @default.
• W3000413955 creator A5091528258 @default.
• W3000413955 date "2020-10-01" @default.
• W3000413955 modified "2023-10-11" @default.
• W3000413955 title "Development and pilot of a prescription drug monitoring program and communication intervention for pharmacists" @default.
• W3000413955 cites W1969067751 @default.
• W3000413955 cites W1972663316 @default.
• W3000413955 cites W2006108411 @default.
• W3000413955 cites W2007283890 @default.
• W3000413955 cites W2027793990 @default.
• W3000413955 cites W2036588559 @default.
• W3000413955 cites W2041723235 @default.
• W3000413955 cites W2093274439 @default.
• W3000413955 cites W2099697766 @default.
• W3000413955 cites W2100509572 @default.
• W3000413955 cites W2108718065 @default.
• W3000413955 cites W2117307996 @default.
• W3000413955 cites W2154654924 @default.
• W3000413955 cites W2154973070 @default.
• W3000413955 cites W2207832751 @default.
• W3000413955 cites W2604887217 @default.
• W3000413955 cites W2625891749 @default.
• W3000413955 cites W2743492109 @default.
• W3000413955 cites W2778794778 @default.
• W3000413955 cites W2782433140 @default.
• W3000413955 cites W2794435427 @default.
• W3000413955 cites W2800278321 @default.
• W3000413955 cites W2807441927 @default.
• W3000413955 cites W2884539190 @default.
• W3000413955 cites W2886657242 @default.
• W3000413955 cites W2890816741 @default.
• W3000413955 cites W2898180531 @default.
• W3000413955 cites W2912601305 @default.
• W3000413955 cites W2942632282 @default.
• W3000413955 cites W2969217694 @default.
• W3000413955 cites W2970078533 @default.
• W3000413955 doi "https://doi.org/10.1016/j.sapharm.2019.12.023" @default.
• W3000413955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31953112" @default.
• W3000413955 hasPublicationYear "2020" @default.
• W3000413955 type Work @default.
• W3000413955 sameAs 3000413955 @default.
• W3000413955 citedByCount "13" @default.
• W3000413955 countsByYear W30004139552021 @default.
• W3000413955 countsByYear W30004139552022 @default.
• W3000413955 countsByYear W30004139552023 @default.
• W3000413955 crossrefType "journal-article" @default.
• W3000413955 hasAuthorship W3000413955A5000479274 @default.
• W3000413955 hasAuthorship W3000413955A5000998928 @default.
• W3000413955 hasAuthorship W3000413955A5032055005 @default.
• W3000413955 hasAuthorship W3000413955A5065055672 @default.
• W3000413955 hasAuthorship W3000413955A5068219229 @default.
• W3000413955 hasAuthorship W3000413955A5084986801 @default.
• W3000413955 hasAuthorship W3000413955A5086002607 @default.
• W3000413955 hasAuthorship W3000413955A5091528258 @default.
• W3000413955 hasConcept C104863432 @default.
• W3000413955 hasConcept C144133560 @default.
• W3000413955 hasConcept C15744967 @default.
• W3000413955 hasConcept C159110408 @default.
• W3000413955 hasConcept C162324750 @default.
• W3000413955 hasConcept C162853370 @default.
• W3000413955 hasConcept C177212765 @default.
• W3000413955 hasConcept C180747234 @default.
• W3000413955 hasConcept C187736073 @default.
• W3000413955 hasConcept C2426938 @default.
• W3000413955 hasConcept C27415008 @default.
• W3000413955 hasConcept C2779356329 @default.
• W3000413955 hasConcept C2780665704 @default.
• W3000413955 hasConcept C509550671 @default.
• W3000413955 hasConcept C56995899 @default.
• W3000413955 hasConcept C71924100 @default.
• W3000413955 hasConceptScore W3000413955C104863432 @default.
• W3000413955 hasConceptScore W3000413955C144133560 @default.
• W3000413955 hasConceptScore W3000413955C15744967 @default.
• W3000413955 hasConceptScore W3000413955C159110408 @default.
• W3000413955 hasConceptScore W3000413955C162324750 @default.
• W3000413955 hasConceptScore W3000413955C162853370 @default.
• W3000413955 hasConceptScore W3000413955C177212765 @default.
• W3000413955 hasConceptScore W3000413955C180747234 @default.
• W3000413955 hasConceptScore W3000413955C187736073 @default.
• W3000413955 hasConceptScore W3000413955C2426938 @default.
• W3000413955 hasConceptScore W3000413955C27415008 @default.
• W3000413955 hasConceptScore W3000413955C2779356329 @default.
• W3000413955 hasConceptScore W3000413955C2780665704 @default.
• W3000413955 hasConceptScore W3000413955C509550671 @default.
• W3000413955 hasConceptScore W3000413955C56995899 @default.
• W3000413955 hasConceptScore W3000413955C71924100 @default.
• W3000413955 hasFunder F4320332177 @default.
• W3000413955 hasIssue "10" @default.
• W3000413955 hasLocation W30004139551 @default.
• W3000413955 hasOpenAccess W3000413955 @default.

• next